▲ SIGMATERMINAL Open Terminal →

Analyses / MA

MA Mastercard Inc As of Jul 30, 2026
$563.32

Premium-valuation payment network with strong earnings growth; watch insider selling and macro sensitivity.

Setup: growth Confidence: 65 Horizon: 3-6 months Risk: medium Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals MA's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

MA trades at 32x P/E with 17.3% EPS growth and 13.8% revenue growth, supported by 57.6% operating margins and 45.6% net margins. Cross-border payment strength (per Visa Q3 beat) and secular digital payment adoption underpin mid-to-high single-digit volume growth. Low beta (0.72) appeals to defensive portfolios. Payout ratio 18.4% leaves room for buybacks/growth reinvestment.

▼ Bear Case

P/E 32x and forward P/E 33.3x price in perfection; P/B 66.3x and P/S 15.2x are extreme. Price/FCF 30.3x leaves minimal margin for earnings misses. Insider selling (107 sells vs 58 buys) and recent modest +0.1% daily move signal complacency. Rising macro uncertainty and potential recession could crimp cross-border volume. Valuation vulnerable if growth decelerates.

Valuation

OVERVALUED on absolute multiples; FAIR relative to growth + quality. — score 42/100

P/E 32x, P/B 66.3x, and P/S 15.2x exceed historical MA medians and S&P 500 averages. However, 17.3% EPS growth, 13.8% revenue growth, and 45.6% net margin justify a premium to market. Forward P/E 33.3x implies modest earnings growth is fully priced; any miss triggers sharp downside.

Technical Levels

Support · $540.00 (20-day MA / key entry zone) · $520.00 (Stop loss; 50-day MA proxy) · $500.00 (Bear case target; psychological support)

Resistance · $575.00 (Day high; near-term ceiling) · $601.77 (52-week high; primary resistance) · $630.00 (Bull case target; psychological level)

RSI: Data unavailable; infer neutral from 0.1% daily move.

Financial Health

Score 82/100. Liquidity appears tight (current/quick ratio ~1.0) but typical for efficient large-caps. Low payout ratio signals dividend sustainability and room for buybacks. Debt metrics unavailable; assume investment-grade rating standard for MA.

Catalysts

Q4 2024 earnings (likely Jan/Feb 2025)4–8 weeksHigh. Watch for EPS growth sustainability, cross-border volume trends, margin guidance, and buyback pace. Beat could re-rate multiple; miss triggers 5–10% pullback.
Fed rate policy / macro dataOngoingMedium. Lower rates may soften volume; stability supports base case.
Insider transactions / 10b5-1 plansOngoingMedium. Continued heavy selling (107:58 ratio) could signal overvaluation; insider buying would rebuild confidence.
M&A or strategic partnershipsSpeculativeMedium. Acquisitions in fintech or data services could unlock growth; overpayment risks exist.

Risk Flags

Insider selling (107 sells vs 58 buys, 263.9k shares sold) — potential overvaluation signal; monitor next filings.
Extreme valuation multiples (P/E 32x, P/B 66.3x, P/S 15.2x) leave little room for earnings disappointment.
Forward P/E 33.3x implies ~3% earnings growth premium already baked in; macro slowdown could trigger rerating.
Recent news mix: Visa earnings beat, Apple swing guidance, and crypto cashback initiatives; MA-specific catalysts thin.
Beta 0.72 suggests defensive positioning, but in bear market defensiveness may not protect premium valuations.
Debt-to-equity, gross margin, and FCF per share data unavailable; liquidity check incomplete.

See MA's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock MA free →

Recent News

More Analyses

MA FAQ

Is MA a buy right now?

Mastercard Inc's current read is a growth setup with 65 confidence over a 3-6 months horizon. Valuation: OVERVALUED on absolute multiples; FAIR relative to growth + quality.. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is MA overvalued?

OVERVALUED on absolute multiples; FAIR relative to growth + quality. (valuation score 42/100). P/E 32x, P/B 66.3x, and P/S 15.2x exceed historical MA medians and S&P 500 averages. However, 17.3% EPS growth, 13.8% revenue growth, and 45.6% net margin justify a premium to market. Forward P/E 33.3x implies modest earnings growth is fully priced; any miss triggers sharp downside.

What are the risks of buying MA?

P/E 32x and forward P/E 33.3x price in perfection; P/B 66.3x and P/S 15.2x are extreme. Price/FCF 30.3x leaves minimal margin for earnings misses. Insider selling (107 sells vs 58 buys) and recent modest +0.1% daily move signal complacency. Rising macro uncertainty and potential recession could crimp cross-border volume. Valuation vulnerable if growth decelerates.